The Impact of Disability on Depression Among Individuals with COPD
Overview
Authors
Affiliations
Background: Both disability and depression are common in COPD, but limited information is available on the time-ordered relationship between increases in disability and depression onset.
Methods: Subjects were members of a longitudinal cohort with self-reported physician-diagnosed COPD, emphysema, or chronic bronchitis. Data were collected through three annual structured telephone interviews (T1, T2, and T3). Depression was defined as a score >/= 4 on the Geriatric Depression Scale Short Form (S-GDS). Disability was measured with the Valued Life Activities (VLA) scale; three disability scores were calculated: percent of VLAs unable to perform, percent of VLAs affected (unable to perform or with some degree of difficulty), and mean VLA difficulty rating. Disability increases were defined as a 0.5 SD increase in disability score between T1 and T2. Multiple logistic regression analyses estimated the risk of T3 depression following a T1 to T2 disability increase for the total cohort and then excluding individuals who met the depression criterion at T1 or T2.
Results: Approximately 30% of subjects met the depression criterion each year. Eight percent to 19% experienced a T1 to T2 disability increase, depending on the disability measure. Including all cohort members and controlling for baseline S-GDS scores, T1 to T2 increases in disability yielded a significantly elevated risk of T3 depression (% affected odds ratio [OR] =3.6; 95% CI, [1.7, 7.7]; % unable OR = 6.1 [17, 21.8]; mean difficulty OR= 3.6 [1.7, 8.0]). Omitting individuals depressed at T1 or T2 yielded even stronger risk estimates for % unable (OR = 13.4 [2.0, 91.4]) and mean difficulty (OR = 3.9 [1.3, 11.8]).
Conclusions: Increases in VLA disability are strongly predictive of the onset of depression.
Effects of Dronabinol on Dyspnea and Quality of Life in Patients With COPD.
Zaid A, Thapamagar S, Anholm J, Weaver-Carnahan L, Duong L, Specht L Chronic Obstr Pulm Dis. 2024; 11(2):206-215.
PMID: 38310543 PMC: 11075348. DOI: 10.15326/jcopdf.2023.0401.
Zuo X, Lou P, Zhu Y, Chen B, Zhu X, Chen P Ther Adv Respir Dis. 2022; 16:17534666221111876.
PMID: 35850588 PMC: 9340361. DOI: 10.1177/17534666221111876.
Gong B, Shang S, Wu C BMJ Open. 2020; 10(10):e040098.
PMID: 33115903 PMC: 7594365. DOI: 10.1136/bmjopen-2020-040098.
Benzo R, Kirsch J, Hathaway J, McEvoy C, Vickers K Respir Care. 2017; 62(11):1403-1411.
PMID: 29061910 PMC: 7315776. DOI: 10.4187/respcare.05574.
Screening for COPD: the gap between logic and evidence.
Kaplan A, Thomas M Eur Respir Rev. 2017; 26(143).
PMID: 28298389 PMC: 9489098. DOI: 10.1183/16000617.0113-2016.